Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | PAT-SM6 |
Synonyms | |
Therapy Description |
PAT-SM6 is a monoclonal antibody directed against GRP78, which may result in increased apoptosis and decreased growth of GRP78-expressing tumor cells, especially in combination with other agents (PMID: 23667612, PMID: 27029491, PMID: 31766302). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PAT-SM6 | PAT-SM6 is a monoclonal antibody directed against GRP78, which may result in increased apoptosis and decreased growth of GRP78-expressing tumor cells, especially in combination with other agents (PMID: 23667612, PMID: 27029491, PMID: 31766302). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|